Objective: To evaluate the safety and cost-effectiveness of Short Stay Intensive Care (SSIC) treatment for low-risk coronary artery bypass patients Design: Randomized clinical equivalence trial Setting: University Hospital Maastricht, the Netherlands Patients: low-risk coronary artery bypass patients Interventions: 600 patients were randomly assigned to undergo either SSIC treatment (8 hours Intensive Care) or control treatment (care as usual, overnight Intensive Care). Measurements: The primary outcome measures were Intensive Care (IC) readmissions and total hospital stay. The secondary outcome measures were total hospital costs, Quality of Life (QoL), postoperative morbidity and mortality. Hospital costs consisted of the cost of hospital admission(s) and outpatient costs.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
597
control group, care as usual, 24 hours intensive care stay
Short-Stay Intensive Care treatment (SSIC), 8 hours of Intensive care treatment
University Hospital Maastricht
Maastricht, Netherlands
Intensive Care (IC) readmissions
Time frame: one month postoperative
total hospital stay, total hospital costs, postoperative morbidity and mortality
Time frame: one month
generic and disease specific Quality of Life (QoL)
Time frame: one year postoperative
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.